WHO ICTRP trial
A controlled Phase 2/3 study of adjuvanted recombinant SARS-CoV-2 trimeric…
EUCTR2020-004272-17-BE · EU Clinical Trials Register · Not Recruiting
Key facts
| Trial ID | EUCTR2020-004272-17-BE |
|---|---|
| Public title | A controlled Phase 2/3 study of adjuvanted recombinant SARS-CoV-2 trimeric S-protein vaccine (SCB-2019) for the prevention of COVID-19 |
| Scientific title | A Double-blind, Randomized, Controlled, Phase 2/3 Study to Evaluate the Efficacy, Immunogenicity, and Safety of CpG 1018/Alum-Adjuvanted Recombinant SARS-CoV-2 Trimeric S-protein Subunit Vaccine (SCB-2019) for the Prevention of SARS-CoV-2-mediated COVID-19 in Participants Aged 12 years and Older… |
| Primary sponsor | Clover Biopharmaceuticals AUS Pty Ltd |
| Registry | EU Clinical Trials Register |
| Recruitment status | Not Recruiting |
| Study type | Interventional clinical trial of medicinal product |
| Phase | Human pharmacology (Phase I): no Therapeutic exploratory (Phase II): yes Therapeutic confirmatory - (Phase III): yes Therapeutic use (Phase IV): no |
| Countries | Colombia;Belgium;Philippines;Brazil;South Africa;Germany |
| Conditions | SARS-CoV-2-mediated COVID-19 MedDRA version: 23.1 Level: LLT Classification code 10084465 Term: COVID-19 vaccination System Organ Class: 100000004865 ;Therapeutic area: Diseases [C] - Virus Diseases [C02] |
| Interventions | Product Name: SCB-2019 (CpG 1018/Alum-djuvanted SCB-2019) Product Code: SCB-2019 Pharmaceutical Form: Solution for injection INN or Proposed INN: Not available Current Sponsor code: SCB-2019 Other descriptive name: SARS-CoV-2 spike trimer… |
| Registration date | Nov 18, 2020 |
| Target size | 30000 |
| Secondary IDs | CLO-SCB-2019-003 |
| Registry page | clinicaltrialsregister.eu |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: